Active drug targeting with immunoconjugates to choroidal neovascularization
Authors:
- 1 January 2000
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 21 (6) , 952-961
Abstract
Purpose. Active drug targeting with monoclonal antibody to neovascular vessels may be a potential treatment for choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Endogli...Keywords
This publication has 24 references indexed in Scilit:
- Targeting the vasculature of solid tumoursJournal of Controlled Release, 1997
- Radiation therapy for ocular choroidal neovascularization (Phase study): Preliminary reportInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor VasculatureScience, 1997
- Electric Charge Influence of Dextran Derivatives on their Tumor Accumulation After Intravenous InjectionDrug Delivery, 1997
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal of Cancer, 1996
- PEG-ADA: An alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiencyHuman Mutation, 1995
- Five-Year Follow-up of Fellow Eyes of Patients With Age-Related Macular Degeneration and Unilateral Extrafoveal Choroidal NeovascularizationArchives of Ophthalmology (1950), 1993
- Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugateBioconjugate Chemistry, 1992
- Regulated expression on human macrophages of endoglin, an Arg‐Gly‐Asp‐containing surface antigenEuropean Journal of Immunology, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990